Evidence map›Paper›PMID 28462370›Full record

ArticleCellular and molecular gastroenterology and hepatology2017

TRIF as a Novel Modulator of Liver Inflammation and Fibrosis.

Natalie J Török

Open access · goldAbstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Cellular and molecular gastroenterology and hepatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Natalie J TörökDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, University of California Davis, Sacramento, California.
University of California, Davis · US

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura Marcu · 2002 to 2026
$84.9M
Phagocytosis and NOX2 in Liver FibrogenesisR01DK083283 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · PI TOROK, NATALIE J. · 2010 to 2019
$3.1M
Diabetes and extracellular matrix in NASHR56DK083283 · NIDDK · STANFORD UNIVERSITY · PI TOROK, NATALIE J. · 2022 to 2022
$304k
The Role of TNF alpha Converting Enzyme in Alcoholic Liver DiseaseI01BX002418 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI Natalie J. Torok · 2014 to 2026
–
BLRD VA I01 BX002418NCI NIH HHS P30 CA093373NIDDK NIH HHS R01 DK083283NIDDK NIH HHS R56 DK083283
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28462370
PMCPMC5404095
OpenAlexW2600219782

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.